is glp-1 safe for breast cancer survivors GLP-1s in Cancer: Overall Survival, Recurrence Risk, and Safety GLP-1 drugs linked to improved
Description
Among these, semaglutide has demonstrated reduced risk of major adverse cardiovascular events (MACE) in trial participants with moderate or high cardiovascular risk
8 Contraindications include medullary thyroid carcinoma, multiple endocrine neoplasia Type 2, and pregnancy
If you have specific concerns or a situation arises in which you require medical advice, you should consult with an appropriately trained and qualified medical services provider.
For comprehensive guidance, review our reconstituted peptide storage guide
Jaworecka K, Pojawa-Golab M, Otto-Buczkowska E, Reich A
